S‐adenosyl methionine as adjunctive treatment vs placebo: Depression remission
S‐adenosyl methionine as adjunctive treatment may leads to higher proportions of participants achieving remission depression rating… compared with placebo (low certainty).
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
S‐adenosyl methionine as adjunctive treatment vs placebo Proportions of participants achieving remission depression rating scale score within the normal range at the end of the study. A larger RR indicates greater response to treatment in the SAMe group · adults with depression S‐adenosyl methionine as adjunctive treatment may leads to higher proportions of participants achieving remission depression rating… compared with placebo (low certainty). S‐adenosyl methionine (SAMe) for depression in adults (2016) · Cochrane Headline outcomes only | RR 3.05 [1.11, 8.39] | 1 study · 73 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| S‐adenosyl methionine (SAMe) for depression in adults 2016 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.